Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
12.08. | AIM Market Roundup: Fiinu, T42 IOT, Polarean | 2 | The Armchair Trader | ||
12.08. | Polarean Imaging PLC - Submission of new Phase III study protocol to FDA | - | RNS | ||
24.06. | Polarean Imaging PLC - Promotion & sales representative agreement | 3 | RNS | ||
09.06. | Polarean Imaging PLC - Result of AGM | - | RNS | ||
02.06. | Polarean: FDA expands XENOVIEW indication to include children from six years of age | 1 | GlobeNewswire (USA) | ||
02.06. | Polarean Imaging gets go-ahead to expand Xenoview use | 1 | Sharecast | ||
POLAREAN IMAGING Aktie jetzt für 0€ handeln | |||||
02.06. | Polarean Imaging PLC - FDA expands XENOVIEW indication | - | RNS | ||
21.05. | Polarean Imaging PLC - Dr. Bastiaan Driehuys awarded by ATS | - | RNS | ||
15.05. | Polarean: Xenon MRI Featured Prominently at ATS 2025 Across Broad Clinical Spectrum | 1 | GlobeNewswire (USA) | ||
15.05. | Polarean Imaging's Xenon-MRT gewinnt an Bedeutung in der Lungenmedizin | 2 | Investing.com Deutsch | ||
15.05. | Polarean Imaging's Xenon MRI gains traction in pulmonary medicine | 1 | Investing.com | ||
15.05. | Polarean Imaging PLC - Xenon MRI featured prominently at ATS 2025 | - | RNS | ||
14.05. | AIM Market Roundup: H&T, Polarean Imaging, Corcel | 2 | The Armchair Trader | ||
14.05. | Polarean Imaging PLC - Ongoing collaboration with Philips | 2 | RNS | ||
08.05. | Polarean Imaging PLC - Final Results | - | RNS | ||
25.04. | Polarean Imaging PLC - Notice of Results | - | RNS | ||
10.03. | Polarean Imaging PLC - Expansion of Xenon MRI imaging platform | 1 | RNS |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MEDTRONIC | 78,90 | -1,58 % | Medtronic erhält grünes Licht für erweitertes Diabetes-System in den USA | Das US-amerikanische Gesundheitsunternehmen Medtronic hat von der Food and Drug Administration (FDA) zwei wichtige Zulassungen für sein MiniMed-780G-System erhalten. Damit erweitert der Konzern die... ► Artikel lesen | |
HCA HEALTHCARE | 348,20 | -0,20 % | $100 Invested In HCA Healthcare 10 Years Ago Would Be Worth This Much Today | ||
LANTHEUS | 47,180 | -0,69 % | Pre-market Movers: Myriad Genetics, LifeMD, Evolus, Lantheus Holdings, Astera Labs | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.15 A.M. ET).In the Green Myriad Genetics, Inc. (MYGN) is up over 30% at $5.04.
Astera... ► Artikel lesen | |
ENVISTA | 18,000 | +1,12 % | Envista Holdings Corporation: Envista Reports Second Quarter 2025 Results | BREA, Calif., July 31, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended June 27, 2025.
"Envista achieved... ► Artikel lesen | |
CAREDX | 11,790 | +2,03 % | CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential | ||
GT BIOPHARMA | 0,922 | +2,41 % | GT Biopharma, Inc. - 8-K, Current Report | ||
SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports Preliminary Fourth Quarter and Fiscal Year 2025 Results | Expects Record Fiscal Year Revenue, Net Income, Adjusted EBITDA and Cash Flow
HENDERSON, Nev., Aug. 19, 2025 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:... ► Artikel lesen | |
CARMAT | 0,072 | -18,18 % | XFRA CXT: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
CHEMOMETEC | 69,50 | +0,43 % | Chemometec A/S: Preliminary revenue figures for the 2024/25 financial year | ANNOUNCEMENT NO. 290 1 July 2025 Preliminary revenue figures for the 2024/25 financial year Based on the preliminary financial figures, ChemoMetec now expects revenue of around DKK 496 million... ► Artikel lesen | |
ARRAIL GROUP | 0,238 | 0,00 % | ARRAIL GROUP (06639): FORM OF PROXY FOR 2025 ANNUAL GENERAL MEETING | ||
DEVYSER DIAGNOSTICS | 13,920 | +2,50 % | Devyser Diagnostics AB: Devyser Diagnostics AB publishes quarterly report for the period April to June 2025 | "A positive operating result was recorded in the second quarter. The effects of the cost-cutting program initiated at the beginning of the year can already be seen in both current costs and in the cost... ► Artikel lesen | |
PROMIMIC | 1,340 | +4,69 % | Curiteva & Promimic - Bonded by Innovation | HUNTSVILLE, ALABAMA / ACCESS Newswire / May 6, 2025 / Curiteva, a leader in 3D-printed Trabecular PEEK implant technology, is pleased to announce an expanded partnership with Promimic, pioneers in nanotechnology... ► Artikel lesen | |
FRESENIUS | 46,520 | +0,04 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für Fresenius von 49 auf 57 Euro angehoben und die Einstufung auf "Buy" belassen. Die Phase steigender Markterwartungen sei bei... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,660 | +0,86 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 41,900 | +0,48 % | Darum fällt der DAX - Außerdem im Fokus: FMC und Deutz | Am Dienstag steht der DAX unter Druck - das belastet den deutschen Leitindex jetzt. Außerdem im Fokus der Börse: die Aktien von FMC und Deutz. Der deutsche Aktienmarkt hat am Dienstag zum Handelsstart... ► Artikel lesen |